Federal award
TRILLAMED LLC
W91YTZ21P0117
Contract
Obligated and Ceiling
- Obligated (net)
- $150,034.78
- Ceiling (potential value, not spending)
- $150,034.78
- Current value
- $150,034.78
- Gross positive obligations
- $224,752.50
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TRILLAMED LLC · GW9FLBWB5625
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TRILLAMED LLC · GW9FLBWB5625
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W91YTZ21P0117
- Award type code
- B
- Actions
- 11 · Jul 1, 2021 to Jun 1, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 1, 2026 | FY2026 | P00010 | M | $0.00 | — |
| Jan 20, 2026 | FY2026 | P00009 | C | −$13,984.60 | — |
| May 18, 2025 | FY2025 | P00008 | G | $44,950.50 | — |
| Feb 13, 2025 | FY2025 | P00007 | D | −$18,779.32 | — |
| Jun 25, 2024 | FY2024 | P00006 | C | $44,950.50 | — |
| May 3, 2024 | FY2024 | P00005 | G | $0.00 | — |
| Jan 9, 2024 | FY2024 | P00004 | C | −$41,953.80 | — |
| Jul 6, 2023 | FY2023 | P00003 | G | $44,950.50 | — |
| Apr 27, 2022 | FY2022 | P00002 | C | $44,950.50 | — |
| Apr 12, 2022 | FY2022 | P00001 | G | $0.00 | — |
| Jul 1, 2021 | FY2021 | 0 | — | $44,950.50 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
